It takes about a year for people with focal epilepsy to start finding some relief from anti-seizure medications, a new study says. In all, 3 of 5 epilepsy patients (60%) do achieve freedom from ...
A new study has found that medications for ADHD have overall small effects on blood pressure and heart rate after weeks or a few months of use. There have been concerns about the side effects of ADHD ...
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests. People who are overweight or obese have a higher risk of getting 13 types of cancer, and ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
Benzodiazepine and antipsychotics — medications that are primarily used to treat symptoms like anxiety, agitation and delirium — may contribute to a higher risk of death among dementia patients in ...
About 4% of seniors can't afford their prescription at all, the study found. Millions of American seniors are having a hard time affording their prescription medications, a new National Health ...
New research uncovers how cultural, social, and healthcare challenges impact medication adherence among women, offering insights to reduce stroke recurrence disparities. Study: Sex Differences in ...
Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...
Higher ranking military officers receive more resources and better care than low ranking military officers, according to an analysis of 1.5 million military ER visits published Thursday in the journal ...
Ozempic, Mounjaro and similar medications for Type 2 diabetes and weight loss could also help people struggling with addiction, according to a new study. Researchers found that people addicted to ...
Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results